Manufacturers Life Insurance Company, The 2seventy Bio, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 18,747 shares of TSVT stock, worth $92,985. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,747
Previous 18,771
0.13%
Holding current value
$92,985
Previous $88,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding TSVT
# of Institutions
126Shares Held
44.5MCall Options Held
17.3KPut Options Held
2.9K-
Kynam Capital Management, LP Princeton, NJ5.95MShares$29.5 Million1.11% of portfolio
-
Goldman Sachs Group Inc New York, NY4.29MShares$21.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.76MShares$18.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$18.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.92MShares$14.5 Million0.0% of portfolio
About 2seventy bio, Inc.
- Ticker TSVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,873,600
- Market Cap $188M
- Description
- 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...